Status:

COMPLETED

Preoperative or Postoperative Therapy of Patients With Stages IB, II, IIIA Non-Small Cell Lung Cancer

Lead Sponsor:

SCRI Development Innovations, LLC

Collaborating Sponsors:

Bristol-Myers Squibb

Eli Lilly and Company

Conditions:

Lung Cancer

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

In this phase II study, we plan to evaluate several novel components of therapy. In patients with potentially resectable stages IIB (T3N0) and IIIA we will compare weekly paclitaxel and carboplatin wi...

Detailed Description

Upon determination of eligibility, neo-adjuvant patients will be randomly assigned to one of two treatment arms: * ARM A Paclitaxel + Carboplatin + Radiation Therapy + Surgery * ARM B Paclitaxel + Ca...

Eligibility Criteria

Inclusion

  • To be included in this study, you must meet the following criteria:
  • Non-small cell lung cancer
  • Neoadjuvant candidates must have potentially resectable disease
  • Adjuvant candidates must have had complete resection
  • Clinical stage IB, II, or IIIA non-small cell lung cancer
  • ECOG performance status 0 or 1
  • Adequate bone marrow, liver and kidney function
  • No previous chemotherapy or radiation therapy for non-small cell lung cancer.
  • Give written informed consent.

Exclusion

  • You cannot participate in this study if any of the following apply to you:
  • Stage IIIA with N2 nodes \> 6 cm
  • Stage IIIB or IV disease
  • Age \<18 years
  • ECOG performance status 2 or higher
  • Considered inoperable based on general medical condition
  • History of prior malignancy within five years
  • Women who are pregnant or lactating
  • Please note: There are additional inclusion/exclusion criteria. The study center will determine if you meet all of the criteria. If you do not qualify for the trial, study personnel will explain the reasons. If you do qualify, study personnel will explain the trial in detail and answer any questions you may have.

Key Trial Info

Start Date :

November 1 2000

Trial Type :

INTERVENTIONAL

End Date :

January 1 2009

Estimated Enrollment :

250 Patients enrolled

Trial Details

Trial ID

NCT00193310

Start Date

November 1 2000

End Date

January 1 2009

Last Update

March 18 2015

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.